Shilov V V, Shikalova I A, Vasil'ev S A, Loladze A T, Batotsyrenov B V
Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(1):45-8.
The examination of 130 patients with an alcohol abused syndrome and a severe ethanol poison have revealed that ethanol action are accompanied by significant metabolic disturbances. The comparative evaluation of the inclusion of heptral and remaxol in the treatment has shown that remaxol improves the clinical course of mentioned disorders decreasing the frequency and duration of alcohol delirium. Patients treated with this drug spent less time in acute care and their treatment duration was shorter. Remaxol reduces more effectively the severity of metabolic disorders.
对130例酒精滥用综合征和严重乙醇中毒患者的检查显示,乙醇作用伴有明显的代谢紊乱。对使用肝得健(Heptral)和瑞美索龙(Remaxol)进行治疗的比较评估表明,瑞美索龙可改善上述疾病的临床病程,减少酒精谵妄的频率和持续时间。使用该药物治疗的患者在急性护理中的时间更短,治疗持续时间也更短。瑞美索龙能更有效地减轻代谢紊乱的严重程度。